Evidence map›Paper›PMID 41999022›Full record

ArticleThe FEBS journal2026

Structural and functional dissection of human neurolysin through alanine-scanning mutagenesis.

Heba ElSayed ElZorkany, Asmaa Aly, Shiva Hadi Esfahani, Vardan T Karamyan

Abstract read
In one paragraph

Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Heba ElSayed ElZorkanyDepartment of Foundational Medical Studies, William Beaumont School of Medicine, Oakland University, Rochester, MI, USA.
Asmaa AlyDepartment of Foundational Medical Studies, William Beaumont School of Medicine, Oakland University, Rochester, MI, USA.
Shiva Hadi EsfahaniDepartment of Foundational Medical Studies, William Beaumont School of Medicine, Oakland University, Rochester, MI, USA.
Vardan T KaramyanDepartment of Foundational Medical Studies, William Beaumont School of Medicine, Oakland University, Rochester, MI, USA.ORCID https://orcid.org/0000-0003-0050-6047

Funding

Development and Characterization of Small Molecule Activators of Peptidase Neurolysin for Stroke TherapyR01NS106879 · NINDS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI Thomas J Abbruscato, Vardan T. Karamyan · 2018 to 2026
$4.2M
NINDS NIH HHS R01 NS106879NINDS NIH HHS R01NS106879
6 · The paper itself

Abstract

Peptidase neurolysin (Nln, EC3.4.24.16) is a zinc-dependent M3 metallopeptidase that regulates key neuropeptide systems, including neurotensin, bradykinin, and substance P. Despite the availability of high-resolution Nln structures, the contribution of individual residues to its catalytic function and structural stability remains incompletely understood. In this study, we systematically examined 24 residues of human Nln using alanine-scanning mutagenesis, steady-state kinetic analysis, and differential scanning fluorimetry (DSF). Mutations were selected to probe residues spanning α helices, flexible loops, and the catalytic channel, categorizing them into two classes: (a) residues critical for structural and conformational stability, and (b) residues involved in substrate recognition and catalysis. Alanine substitutions near the catalytic core (H425, F453, S506, and H601) or within the flexible loop at the base of the catalytic channel (E498 and T499) caused severe or complete loss of enzymatic activity, underscoring their essential roles in substrate binding and active-site geometry. Substitutions disrupting peripheral salt bridges (E73 and R141) predominantly affected thermal stability without markedly altering catalytic efficiency. Conversely, variants K145A and R491A retained activity with potential trends toward enhanced turnover, identifying these regions as permissive sites that may support gain-of-function modulation. Collectively, our findings define the residue-level determinants of Nln activity and stability, highlighting how local interactions at the catalytic channel, flexible loops, and key helices govern the conformational dynamics of the enzyme. This work provides a molecular framework for understanding the allosteric pathways in Nln and for designing small-molecule modulators.

Indexed as

AlanineMetalloendopeptidasesAmino Acid SequenceAmino Acid SubstitutionCatalytic DomainHumansKineticsModels, MolecularMutagenesisMutagenesis, Site-DirectedProtein ConformationSubstrate SpecificityAlanineMetalloendopeptidasesneurolysinactivating point‐mutationenzymeinhibitory point‐mutationneuropeptidesubstrate recognition

Identifiers

PMID41999022
PMCPMC13489526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.